The India in vitro diagnostics market size was valued at USD 394.76 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.6% from 2024 to 2030. Rising infectious disease testing, chronic disease burden, and a robust lab network drive India's booming in vit... Read More »
February 2024The U.S. point-of-care molecular diagnostics market size was estimated at USD 3.35 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 1.7% from 2024 to 2030. The growth of the market is driven by rise in end-user awareness, along with the increased effici... Read More »
February 2024The global Guillain-Barre Syndrome (GBS) market size was valued at USD 610.5 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.77% from 2023 to 2030. Rising incidence of Guillain-Barre syndrome (GBS), specifically in regions with high rate of infectio... Read More »
February 2024The global montelukast sodium market size was valued at USD 450.0 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 15.6% from 2024 to 2030. The growing prevalence of allergies and rising geriatric population are some of the key drivers for this market. M... Read More »
February 2024The global chemotherapy-induced neutropenia (CIN) treatment market size was valued at USD 617.8 million in 2022 and is expected to grow at a CAGR of 3.45% over the forecast period. The global market is mainly driven by the rising prevalence of cancer, the increased use of chemotherapy in... Read More »
February 2024The North America cannabidiol market size was estimated at USD 6.7 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 14.2% from 2024 to 2030. The CBD market size is expected to grow with the increasing legalization of hemp-based products. Companies are de... Read More »
February 2024The global lice treatment market was valued at USD 975.8 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.22% from 2023 to 2030. The rising prevalence of lice infestations, changing lifestyles, and product innovations are anticipated to impel the growt... Read More »
February 2024The global specimen validity testing market size was valued at USD 2.50 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.49% from 2023 to 2030. This can be attributed to the growing screening initiatives undertaken by the government that aimed at reduc... Read More »
February 2024The global microbial lipase market size was valued at USD 557.44 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.52% from 2023 to 2030. This can be attributed to the growing inclination of consumers towards ready-to-eat food items and the growing numb... Read More »
February 2024Gastroparesis Drugs Market Size & Trends The global gastroparesis drugs market size was valued at USD 4.6 billion in 2023 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 4.6 % from 2024 to 2030. The growth is due to multiple factors, including the increased prevale... Read More »
February 2024The global androgenetic alopecia market size was estimated at USD 2.72 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.45% from 2024 to 2030. The market growth is attributed to increasing demand for therapeutics due to the rising incidence of androgen... Read More »
February 2024The global antisense and RNAi therapeutics market was estimated at USD 4.38 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 18.72% from 2024 to 2030. Antisense technology is useful for gene expression manipulation, which has been recognized as a success... Read More »
February 2024The global morphine drugs market size was valued at USD 23.86 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.69% from 2024 to 2030. The wide use of morphine in pain management is anticipated to drive the market growth. Furthermore, the prevalence of ... Read More »
February 2024The global vitamin D therapy market size was valued at USD 2.04 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.06% from 2024 to 2030. The vitamin D therapy market is being driven by the growing awareness of the health benefits associated with vitamin... Read More »
February 2024The global loratadine market size was valued at USD 153.4 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 2.9% from 2024 to 2030. The high prevalence rate of allergies worldwide, changing lifestyles, and favorable regulatory landscape are significant as... Read More »
February 2024The global tinea pedis treatment market was valued at USD 1.3 billion in 2023 and is expected to grow at a CAGR of 7.09 % from 2024-2030. The market is experiencing growth due to the increasing prevalence of fungal foot infections globally, changing lifestyles, rising awareness about the... Read More »
February 2024The global cough remedies market size was valued at USD 9.90 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.51% from 2024 to 2030. Asthma, chronic pulmonary obstructive disease (COPD), cold, flu, bronchitis, pertussis, and allergies are some of the m... Read More »
February 2024The global hydroxyzine market size is expected to grow at a compound annual growth rate (CAGR) of over 6.0% from 2024 to 2030. The growing prevalence of anxiety disorders and atopic contact dermatitis has created immense opportunities for key market players. In addition, some of the othe... Read More »
February 2024The global fungal keratitis treatment market size was valued at USD 928.9 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.09% from 2024 to 2030. Fungal keratitis, an infection affecting the cornea, the transparent covering over the eye’s-colored... Read More »
February 2024The global graft versus host disease (GvHD) treatment market size was valued at USD 2.8 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2030. The rise in the elderly population and an increase in the occurrence of nephrological, leukem... Read More »
February 2024